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Summary
The goal of this study was to investigate whether intra-
venous infusion of 1000 ml 40% calcium borogluconate 
combined with the oral adminstration of 500 g sodium 
phosphate leads to a better cure rate and longer-lasting 
normocalcaemia and normophosphataemia than stand-
ard intravenous treatment with 500 ml calcium boro-
gluconate in cows with parturient paresis. Forty recum-
bent cows with hypocalcaemia and hypophosphataemia 
were alternately allocated to group A or B. Cows of both 
groups were treated intravenously with 500 ml 40% cal-
cium borogluconate, and cows of group B additionally 
received another 500 ml calcium borogluconate via slow 
intravenous infusion and 500 g sodium phosphate ad-
ministered via an orogastric tube. Thirty-two cows stood 
within 8 hours after the start of treatment and 8 did not; 
of the 32 cows that stood, 18 belonged to group A and 
14 to group B (90% of group A vs. 70% of group B; 
P = 0.23). Seven cows relapsed; of these and the 8 that 
did not respond to initial treatment, 10 stood after two 
standard intravenous treatments. Downer cow syn-
drome occurred in 5 cows, 3 of which recovered after 
aggressive therapy. The overall cure rate did not differ 
significantly between groups A and B. Twelve (60%) 
cows of group A and 14 (70%) cows of group B were 
cured after a single treatment and of the remaining 14, 
11 were cured after two or more treatments. Two down-
er cows were euthanized and one other died of heart 
failure during treatment. Serum calcium concentrations 
during the first eight hours after the start of treatment 
were significantly higher in group B than in group A, 
and oral sodium phosphate caused a significant and 
lasting increase in inorganic phosphate. More cows of 
group B than group A were cured after a single treatment 
(P > 0.05). These findings, although not statistically sig-
nificant, are promising and should be verified using a 
larger number of cows.
Keywords: cattle, parturient paresis, treatment, calcium  
infusion, oral sodium phosphate
Behandlung der Gebärparese von  
Kühen mit Kalzium intravenös und 
Natriumphosphat per os
Es wurde untersucht, ob bei Kühen mit Gebärparese mit 
1000 ml einer 40%igen Kalziumboroglukonatlösung 
intravenös und 500 g Natriumphosphat per os häufiger 
eine anhaltende Normokalzämie und Normophos-
phatämie und ein besserer Therapieerfolg als mit 500 ml 
Kalziumboroglukonatlösung allein erreicht werden 
kann. Die Untersuchungen wurden an 40 Milchkühen 
mit Gebärparese durchgeführt. Alle Kühe hatten initial 
eine Hypokalzämie und eine Hypophosphatämie. Die 
Kühe wurden alternierend zwei Behandlungsgruppen A 
und B à je 20 Kühe zugeteilt. Die Kühe beider Gruppen 
wurden intravenös mit 500 ml einer 40%igen Kalzium-
boroglukonatlösung behandelt. Die Kühe der Gruppe B 
erhielten zusätzlich 500 ml Kalziumboroglukonat als 
Dauertropfinfusion und 500 g Natriumphosphat per 
Nasenschlundsonde. Innerhalb von 8 Stunden standen 
32 Kühe auf und 8 nicht. Von den 32 aufstehenden Kü-
hen gehörten mit 18 Kühen (90%) mehr Tiere zur Grup-
pe B als zur Gruppe A mit 14 Kühen (70%) (P = 0.23). 
Bei 7 der aufgestandenen 32 Kühe kam es zu einem 
Rezidiv. Von den 7 Rezidivkühen und den 8 Kühen, die 
innerhalb von 8 Stunden nicht aufstanden, standen 
nach erneuter Kalziuminfusion 10 Kühe auf. 5 Kühe 
entwickelten ein Downer-Cow-Syndrom. Davon wur-
den 3 Kühe nach intensiver Therapie geheilt. Der Ge-
samtbehandlungserfolg unterschied sich zwischen den 
beiden Gruppen nicht signifikant. In der Gruppe A 
wurden 12 (60%) und in der Gruppe B 14 Kühe (70%) 
nach einer einmaligen Behandlung gesund. Von den 
restlichen 14 Kühen standen 11 nach zwei- bis mehrma-
liger Behandlung auf. Zwei Kühe mussten wegen Dow-
ner-Cow-Syndroms euthanasiert werden, eine Kuh starb 
an Herzversagen. Die Behandlung führte bei den Kühen 
der Gruppe B in den ersten 8 Stunden zu signifikant 
höheren Kalziumkonzentrationen im Blut als bei der 
Gruppe A. Im Weiteren kam es bei der Gruppe B durch 
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Introduction
The standard treatment for parturient paresis is the in-
travenous administration of a calcium solution (Rados-
tits et al., 2007). Forty-seven (Salis, 2002; Braun et al., 
2004a) to 76% (Malz and Meier, 1992) of affected cows 
respond to a single treatment. Some cows relapse and 
require multiple treatments and some do not respond 
to treatment and are euthanized. For more than 10 years, 
we have been conducting studies aimed at improving 
the success rate of the treatment for parturient paresis 
using different protocols including slow intravenous 
infusion of calcium over several hours (Salis, 2002; 
Braun et al., 2004a, 2004b), doubling of the calcium 
dose ( Jehle, 2004; Braun et al., 2006), oral (Dumelin, 
2005; Braun et al., 2007) or intravenous administration 
of sodium phosphate in addition to intravenous admin-
istration of calcium (Zulliger, 2008; Braun et al., 2009) 
and intravenous and oral calcium and phosphorus (Blat-
ter, 2011; Braun et al., 2012). Unfortunately, none of 
those treatments improved the success rate significantly; 
all treatments failed to produce a rapid increase in serum 
calcium and phosphorus concentrations that persisted 
for 48 to 76 hours. Doubling of the standard intravenous 
calcium dose caused hypercalcaemia or normocalcae-
mia that lasted for several hours (Braun et al., 2006), 
and the oral administration of 300 g monosodium phos-
phate resulted in transient normalisation of the inorgan-
ic phosphate concentration (Braun et al., 2007a). In an 
attempt to improve on those results, the same two treat-
ments were combined in the present study and the 
amount of phosphate was increased to 500 g. The goal 
was to compare intravenous administration of 1000 ml 
of a 40% calcium borogluconate solution combined 
with oral administration of 500 g sodium phosphate 
with the standard single administration of 500 ml of the 
same calcium solution for the treatment of parturient 
paresis and generation of sustained normocalcaemia and 
normophosphataemia.
die Verabreichung von Natriumphosphat zu einem 
signifikanten und dauerhaften Anstieg der anorgani-
schen Phosphatkonzentration im Blut. Der Prozentsatz 
an Kühen, die innerhalb von 8 Stunden aufstanden und 
nach einer Behandlung geheilt waren, war bei der Grup-
pe B grösser als bei der Gruppe A (P > 0.05). Es sind 
weitere Untersuchungen mit grösseren Tierzahlen erfor-
derlich, um die Ergebnisse zu belegen.
Schlüsselwörter: Rind, Gebärparese, Therapie, Kalzium-
infusion, Natriumphosphat per os
Animals, Material and Methods
Cows
Forty cows that had parturient paresis within 48 hours 
after parturition (median, 15.3 hours) were used. The 
cows originated from 33 herds serviced by the ambula-
tory clinic at the Department of Farm Animals, Univer-
sity of Zurich, were between 5 and 10 years of age (mean 
± sd = 7.4 ± 1.7 years) and belonged to the Swiss 
Fleckvieh (n=25), Holstein Friesian (n=9) and Brown 
Swiss (n=6) breeds. The lactation numbers ranged from 
1 to 8 (mean, 5.0 ± 1.6) and the production in the pre-
vious lactations ranged from 5’600 to 14’000 kg (mean, 
8’448 ± 1’661 kg). The cows were treated 1 to 8 hours 
(median, 3 hours) after they had become recumbent; 
this time interval did not differ between treatment 
groups.
Clinical examination and diagnosis
All cows underwent a thorough clinical examination as 
described by Rosenberger (1990). Parturient paresis was 
diagnosed when cows became recumbent within 
24 hours after normal parturition and had hypocalcae-
mia and hypophosphataemia.
Treatment
The cows were divided randomly into 2 groups of 
20 cows each. All cows (groups A and B) received 500 ml 
of 40% calcium borogluconate supplemented with 6% 
magnesium hypophosphite (15.65 g calcium gluconate 
and borogluconate, 9.85 g magnesium hypophosphite: 
Calcamyl-40MP, Gräub, Bern) via an indwelling jugular 
vein catheter. During the infusion, which was given over 
ten minutes, the heart rate and rhythm were monitored 
continuously. Cows of group B also received another 
500 ml of the same calcium borogluconate solution add-
ed to 10 litres of a solution of 90 g sodium chloride and 
500 g glucose and administered via a slow intravenous 
drip over a six-hour period (1.7 l/hour). Immediately 
after the start of the infusion, a solution of 500 g mono-
sodium phosphate (NaH2PO4; Hänseler AG, Herisau) 
in 1 liter of water was administered into the rumen via 
an orogastric tube. The total amount of administered 
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metabolisable electrolytes were 15.7 g calcium and 2.8 g 
magnesium per cow in group A and 31.4 g calcium, 5.6 g 
magnesium and 100 g phosphorus per cow in group B. 
Before the start of the treatment, all cows were turned 
onto their other side and the hind limbs were hobbled. 
After the initial rapid calcium infusion, heart rate, res-
piratory rate, rectal temperature, superficial body tem-
perature, rumen motility, appetite and defecation were 
monitored every hour for 8 hours. Attempts to rise, the 
ability to stand and the progression of the disease were 
also noted. Cows that did not attempt to rise were en-
couraged to do so every hour by loud voice commands 
and manual slaps on the croup; when this was unsuc-
cessful, a maximum of two gentle strikes with a cattle 
prod were used. Cows that remained recumbent were 
turned again after 4 hours.
Treatment of cows that did not respond  
or relapsed
Cows that did not stand within 8 hours after the begin-
ning of the treatment or became recumbent again after 
successful initial treatment were given another 500 ml 
of 40% calcium borogluconate and 2 g ketoprofen 
(Rifen 10%, Streuli, Uznach), both administered intra-
venously.
Blood examination and urinalysis
Blood samples were collected from all the cows into 
vacuum tubes (Vacuette® Serum Sep. Clot Activator, 
5 ml, Greiner bio-one GmbH, Kremsmünster, Austria) 
immediately before treatment and 10, 20, 40, 60, 90 
minutes and 2, 3, 4, 5, 6, 7, 8, 24, 48 and 72 hours after 
the beginning of treatment for the determination of the 
concentrations of total and ionised calcium, inorganic 
phosphate and magnesium. The concentrations of cal-
cium, inorganic phosphate and magnesium were deter-
mined at 37 °C with a Cobas Integra 700 analyser (Roche 
Diagnostics, Rotkreuz), using Roche reagents under 
conditions defined by the International Federation of 
Clinical Chemists. The concentration of ionised calci-
um was measured using potentiometry (Rapidpoint 400, 
Siemens Healthcare, Zürich). Urine samples were tested 
for ketone bodies before the start of treatment.
Statistical analysis
Data were analysed using Stata (StataCorp LP, College 
Station, Texas, USA). Frequencies, means and standard 
deviations were calculated. Normal distribution of con-
tinuous data was examined using the Wilk-Shapiro test. 
Normal data were reported as mean ± standard devia-
tion and non-normal data as median and range. Differ-
ences between continuous data were analysed using a 
two-sided paired or unpaired t-test and differences be-
tween categorical data were analysed using a chi-square 
test for association. P < 0.05 was considered significant.
Results
Clinical findings before treatment
Cows of group A were anorexic (n = 15) or had a reduced 
appetite (n = 5) and in group B all cows were anorexic 
(chi2 test, P < 0.05). Other clinical variables did not dif-
fer between the groups and therefore are presented for 
both groups combined. Thirteen cows had a normal 
demeanour, 15 were obtunded, 10 were somnolent and 
2 were comatose. The latter 2 cows were in lateral re-
cumbency and the remaining 38 were in sternal recum-
bency. The heart rate ranged from 40 to 120 beats per 
min (median, 68 bpm) and the rectal temperature 
ranged from 36.4 to 39.4 °C (38.1 ± 0.73 °C). The super-
ficial body temperature was lower than normal in 
34 cows. Rumen motility was absent in 35 cows and 
reduced in the remaining 5. Intestinal motility was ab-
sent in 27 cows and 6 cows passed small amounts of dry 
faeces. Low levels of ketone bodies were detected in the 
urine of one cow. The clinical findings have been de-
scribed in detail (Grob, 2015).
Clinical findings after treatment  
and response to treatment
The course of the disease did not differ significantly 
between the two groups. The demeanour normalised 
after the start of treatment in all but one cow and the 
mean rectal temperature returned to the reference inter-
val within 3 hours. Appetite returned to normal in 
30 cows within 7 hours and all but 2 cows had rumen 
motility 8 hours after the start of treatment. Thirty-four 
cows defecated at least once during the eight-hour ob-
servation period.
Thirty-two cows stood within 8 hours after the start of 
treatment and 8 did not. Eighteen of the responding 
cows belonged to group B and 14 belonged to group A 
(90% versus 70%, P = 0.23). Seven of the initially re-
sponding cows relapsed (three from group A and four 
from group B). Of the 7 cows that relapsed and the 8 
that did not respond to the initial treatment, 10 stood 
after a second calcium infusion. The other 5 became 
downer cows, and 3 of these recovered. The overall re-
covery rate did not differ between groups (group A, 
18/20 [90%]; group B 19/20 [95%]). Twelve cows (60%) 
of group A and 14 cows (70%) of group B responded to 
the initial treatment (Tab. 1). Of the remaining 14 cows, 
11 (group A, 6; group B, 5) stood after two or more 
treatments. Two cows (group A) failed to respond to 
treatment and were euthanized and one cow of group 
B died during a follow-up treatment of acute heart fail-
ure.
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Serum concentrations of electrolytes  
before treatment
The serum concentrations of electrolytes before treat-
ment did not differ between groups. All cows had hy-
pocalcaemia with total calcium less than 2.0 mmol/l 
(0.54 to 1.97 mmol/l; 1.07 ± 0.39 mmol/l) and hy-
pophosphataemia with inorganic phosphate less than 
1.30 mmol/l (0.16 to 1.18 mmol/l; 0.50 ± 0.26 mmol/l). 
Ionised calcium ranged from 0.20 to 0.98 mmol/l (0.51 
± 0.22 mmol/l) and magnesium, which was decreased 
in one cow, ranged from 0.59 to 1.77 mmol/l (1.24 ± 
0.25 mmol/l. Total calcium and ionised calcium con-
centrations (r = 0.97, P < 0.01) and total calcium and 
inorganic phosphate concentrations (r = 0.46, P < 0.01) 
were significantly correlated.
Serum concentrations of electrolytes after 
the start of treatment
The profiles of total calcium differed significantly be-
tween the groups (Fig. 1). Total calcium increased sharp-
ly and significantly after the start of treatment, and 
within 10 minutes, the cows of both groups had tran-
sient hypercalcaemia. The peak at 10 minutes was fol-
lowed by a gradual and slow decrease in calcium con-
centration. Cows of group A were hypercalcaemic for 
2 hours, normocalcaemic between 2 and 7 hours and 
hypocalcaemic at 24 hours. Cows of group B were hy-
percalcaemic for 7 hours, normocalcaemic at 8 hours 
and hypocalcaemic from 24 to 72 hours. The calcium 
concentration was significantly lower (P < 0.05) in group 
B than in group A from 24 to 72 hours. The number of 
cows with hypocalcaemia at eight, 24, 48 and 72 hours 
differed significantly between the two groups (Tab. 2). 
At 8 hours, there were more hypocalcaemic cows in 
group A (7 vs. 1, P < 0.05) and at 72 hours, there were 
more hypocalcaemic cows in group B (3 vs. 12, P < 0.01). 
The concentrations of ionised calcium were analogous 
to those of total calcium (Fig. 2).
As expected, inorganic phosphate was not affected by 
the treatment in group A and remained below the refer-
ence interval for 24 hours (Fig. 3). Cows of group B had 
normophosphataemia from 90 minutes until 72 hours. 
There were significantly more hypophosphataemic cows 
at eight and 24 hours in group A than in group B (8 
hours, 14 vs. 5; 24 hours, 14 vs. 4; P < 0.05) (Tab. 2).
The magnesium profiles were similar in both groups 
(Fig. 4), but the concentrations were significantly high-
er in group B than in group A from 40 minutes to 
7 hours (P < 0.05). The concentration increased sharply 
and significantly (P < 0.01) within 10 minutes, after 
which time it decreased gradually. 
Table 1: Response to treatment in 40 cows with parturient paresis.
Response to treatment Group A Group B Total
Cured after single treatment 12 (60.0%) 14 (70.0%) 26 (65.0%)
Cured after more than one treatment 6 (30.0%) 5 (25.0%) 11 (27.5%)
Not cured 2 (10.0%) 1 (5.0%)* 3 (7.5%)
* Heart failure and death during relapse treatment with calcium borogluconate
Figure 1: Serum concentrations (means ± standard deviations) of total calcium after in-
travenous infusion of calcium borogluconate (group A) and after intravenous infusion of 
calcium borogluconate combined with oral administration of sodium phosphate (group 
B). The yellow shaded area indicates the reference interval of 2.00 to 2.80 mmol/l for total 
calcium.
Figure 2: Serum concentrations (means ± standard deviations) of ionised calcium after 
intravenous infusion of calcium borogluconate (group A) and after intravenous infusion 
of calcium borogluconate combined with oral administration of sodium phosphate (group 
B). The yellow shaded area indicates the reference interval of 1.06 to 1.26 mmol/l for ion-
ised calcium.
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Relationship between electrolyte concen-
trations and response to treatment
The pretreatment electrolyte concentrations and the 
profiles of total and ionised calcium, inorganic phos-
phate and magnesium after treatment did not differ 
significantly between the 32 cows that stood within 
eight hours of the start of treatment and the eight cows 
that did not.
Discussion
The clinical findings of the cows with parturient paresis 
were in agreement with those of other studies (Salis, 
2002; Jehle, 2004; Dumelin, 2005; Zulliger, 2008; Blat-
ter, 2012) and are not discussed further. Pretreatment 
calcium, inorganic phosphate and magnesium were 
1.2 ± 0.45, 0.5 ± 0.26 and 1.2 ± 0.25 mmol/l, respec-
tively, which were in agreement with previously report-
ed means of 1.0 to 1.2 mmol/l for calcium, 0.4 to 
0.6 mmol/l for inorganic phosphate and 1.2 to 
1.3 mmol/l for magnesium (Salis, 2002; Jehle, 2004; 
Dumelin, 2005; Zulliger, 2008; Blatter, 2012). The mean 
concentration of ionised calcium in the present study 
was 0.5 ± 0.22 mmol/l, which was similar to that of the 
previous reports (0.6 to 0.7 mmol/l). Based on the clas-
sification system of Kvart et al. (1982), 57.5% of the cows 
had severe hypocalcaemia, which was higher than the 
range of 26.7 to 50.0% observed in earlier studies (Kvart 
et al., 1982; Salis, 2002; Jehle, 2004; Dumelin, 2005; 
Zulliger, 2008; Blatter, 2012).
The calcium profile of group A was very similar to those 
of previous studies, in which the control cows received 
the same treatment as in the present study (Salis, 2002; 
Dumelin, 2005; Blatter, 2012). After rapid intravenous 
calcium administration, cows were hypercalcaemic for 
about 2 hours, normocalcaemic for another five hours 
and then hypocalcaemic again. The calcium profile of 
group B was very similar to that seen in another study 
Table 2: Number of cows with hypocalcaemia and hypophosphataemia at different time points after the start of treatment.
Hours after start of treatment Hypocalcaemia  
(calcium < 2.0 mmol/l)
Hypophosphataemia  
(inorganic phosphate < 1.3 mmol/l)
Group A Group B Group A Group B
0 20 0 20 20
8a 7 1* 14 5*
24b 13 18 14 4*
48 9 13 7 3
72c 3 12** 6 2
** Difference to group A: P < 0.05, chi2 test
** Difference to group A: P < 0.01, chi2 test
a Calcium and inorganc phosphate differ between groups (P < 0.05, chi2-test)
b Inorganic phosphate differs between groups (P < 0.05, chi2-test)
c Calcium differs between groups (P < 0.01, chi2-test)
Figure 4: Serum concentrations (means ± standard deviations) of magnesium after intra-
venous infusion of calcium borogluconate (group A) and after intravenous infusion of 
calcium borogluconate combined with oral administration of sodium phosphate (group 
B). The yellow shaded area indicates the reference interval of 0.80 to 1.00 mmol/l for mag-
nesium.
Figure 3: Serum concentrations (means ± standard deviations) of inorganic phosphate 
after intravenous infusion of calcium borogluconate (group A) and after intravenous infu-
sion of calcium borogluconate combined with oral administration of sodium phosphate 
(group B). The yellow shaded area indicates the reference interval of 1.30 to 2.30 mmol/l 
for inorganic phosphate.
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in which cows also received 1000 ml calcium boroglu-
conate and were hypercalcaemic for 7 hours, then nor-
mocalcaemic for a short period of time and hypocalcae-
mic at 24 and 48 hours ( Jehle 2004). Similar to previous 
findings ( Jehle, 2004), cows of group B had lower calci-
um concentrations at 24, 48 and 72 hours than cows of 
group A, possibly because of longer-lasting hypercalcae-
mia in the former. It has been shown that within min-
utes, hypercalcaemia results in a drastic decrease in 
parathormone concentration and increased renal excre-
tion of calcium (Goff, 1999). Parathormone concentra-
tion decreased sharply within 10 minutes after calcium 
infusion and remained at a low level for a few hours 
(Zulliger, 2008) or days (Dumelin, 2002). Hypercalcae-
mia also causes calcitonin secretion from the thyroid 
(Pearse, 1966; Care et al., 1970) and in turn inhibits bone 
resorption and stimulates urinary excretion of calcium. 
These mechanisms may have accounted for the lower 
calcium concentrations from 24 to 72 hours in group B.
The serum inorganic phosphate concentration increased 
markedly within 90 minutes after oral administration 
of 500 g sodium phosphate to cows of group B. A dose 
of 350 g gave similar but slightly lower inorganic phos-
phate concentrations (Dumelin, 2005; Braun et al., 
2007b); 80% of cows had normo- or hyperphosphatae-
mia 24 hours after the administration of 500 g sodium 
phosphate compared with 53% after the administration 
of 350 g (Dumelin, 2005; Braun et al., 2007). Several 
studies have shown that oral administration of sodium 
phosphate is effective in increasing the serum inorgan-
ic phosphate concentration in hypophosphataemic cows 
(Cheng et al., 1998; Dumelin, 2005; Zulliger, 2008). A 
recent study showed that monosodium and monopotas-
sium phosphate are equally effective, whereas mono-
calcium phosphate has a less pronounced effect on the 
serum inorganic phosphate concentration (Idink and 
Grünberg, 2015). Sixty-five per cent of all cows were 
cured after a single treatment, which was considerably 
higher than the cure rates of 37% (Blatter, 2011), 46.7% 
(Salis, 2002; Jehle, 2004; Dumelin, 2005) and 56.7% 
(Zulliger, 2008) obtained previously at our clinic, but 
similar to rates observed by other authors (66.0%, Bos-
tedt et al., 1979; 66.5%, Lesch and Gelfert, 2006; 73.5%, 
Siegwart and Niederer, 2005). Fourteen cows (70%) of 
group A and 18 cows (90%) of group B stood within 
8 hours after the start of treatment. Increasing the dose 
of sodium phosphate from 350 g (Dumelin, 2005; Braun 
et al., 2007a) to 500 g increased the recovery rate numer-
ically from 80 to 90%. Although cure rates did not dif-
fer significantly between groups A and B, these results 
and those by Dumelin (2005) suggest that adding oral 
sodium phosphate to the standard intravenous treat-
ment of 500 ml calcium borogluconate improves the 
treatment outcome in cows with parturient paresis. They 
also corroborate the role of hypophosphataemia in the 
pathogenesis of parturient paresis, which recently has 
been studied experimentally in dairy cows (Grünberg 
et al., 2015). Within 9 days of dietary phosphorus dep-
rivation, the plasma inorganic phosphate concentration 
decreased on average by 60%, and by 2 weeks, electro-
myographic examination showed increased occurrence 
of pathological spontaneous activity in striated muscle 
in several cows (Grünberg et al., 2015). This spontane-
ous muscle activity is suggestive of neuromuscular mem-
brane instability and of the involvement of hypophos-
phataemia in the pathogenesis and perpetuation of 
parturient paresis. From a clinical point of view, the 
rapid resolution of the recumbent state is critical to pre-
vent downer cow syndrome. A relapse after an initial 
response to treatment is considerably less detrimental 
than a total lack of response. Experimentally-induced 
downer cow syndrome (healthy anaesthetised cows 
maintained in sternal recumbency) resulted in ischaemic 
muscle necrosis of the pelvic limb that was positioned 
under the body after 6 to 12 hours of recumbency (Cox 
et al., 1982). In the current study, 2 cows of group A but 
none of group B had to be euthanized because of down-
er cow syndrome; in the study by Dumelin (2005), 
2 cows of the control group and one cow that received 
oral phosphorus had downer cow syndrome. The relapse 
rate did not differ between the two groups and the over-
all rate was 17.5%. This was higher than in some studies 
(6.6%, Zulliger, 2008; 13.0%, Salis, 2002) and lower 
than in others (20.0%, Dumelin, 2005); 23.3%, Jehle, 
2004; 33.3%, Blatter, 2012). Other authors reported 
relapse rates of 23 to 40% (Oetzel, 1988; Martig, 2002). 
The proportion of downer cows was 17.5%, which was 
similar to other reports (Kvart et al., 1982, 10.1%; Salis, 
2002, 13.3%; Jehle, 2004, 13.3%; Zulliger, 2008, 13.3%; 
Blatter, 2012, 16.6%). There were slightly more downer 
cows in group A than in group B (4 vs. 1, P = 0.09).
Conclusion
Supplementation of the standard intravenous treatment 
with 500 g sodium phosphate administered orally to 
cows with parturient paresis caused normal or elevated 
serum inorganic phosphate concentration in 80% of 
cows. The response rate to the initial treatment was 90% 
in cows that received oral sodium phosphate in addition 
to intravenous calcium and 70% in cows treated with 
intravenous calcium alone. These findings, although not 
statistically significant, are promising and should be 
verified using a larger number of cows.
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Traitement de la parésie post-partum 
des vaches au moyen de calcium 
intraveineux et de phosphate de 
sodium oral
On a étudié si on pouvait obtenir plus souvent, chez les 
vaches souffrant de parésie post-partum auxquelles on 
administrait par voie intraveineuse 1000 ml d’une solu-
tion à 40% de borogluconate de calcium et par voie orale 
500 g de phosphate de sodium, une normo-calcémie et 
normo-phosphatémie durable et un meilleur résultat 
thérapeutique que chez les animaux recevant unique-
ment 500 ml de la solution de borogluconate de calcium. 
Les essais ont été faits sur 40 vaches laitières souffrant 
de parésie post-partum qui présentaient toutes initiale-
ment une hypocalcémie et une hypophosphatémie. Les 
animaux ont été répartis alternativement en deux 
groupes de traitement A et B, comprenant chacun 
20 vaches. Les animaux des deux groupes ont été traités 
avec 500 ml d’une solution à 40% de borogluconate de 
calcium par voie intraveineuse. Ceux du groupe B ont 
reçu en outre 500 ml de borogluconate de calcium en 
perfusion continue et 500 g de phosphate de sodium par 
sonde naso-oesophagienne.  En l’espace de 8 heures, 
32 vaches se sont levées et 8 pas. Parmi les 32 vaches qui 
se sont levées, 18 appartenaient au groupe B (90%) et 14 
au groupe A (70%) (P = 0.23). Chez 7 des 32 vaches qui 
se sont levées, on a observé une récidive. Parmi les 7 cas 
de récidive et les 8 vaches qui ne s’étaient pas levées après 
8 heures, 10 animaux se sont levés après une deuxième 
perfusion de calcium. Cinq vaches ont développé un 
Downer-Cow-Syndrom, dont trois purent être guéries 
après un traitement intensif. Le succès thérapeutique 
global ne diffère pas significativement d’un groupe à 
l’autre. Dans le groupe A, 12 animaux (60%) ont été 
guéris après un seul traitement et, dans le groupe B 14 
(70%). Sur le solde de 14 vaches, 11 se sont relevées après 
deux ou plusieurs traitements. Deux vaches ont dû être 
euthanasiées pour un Downer-Cow-Syndrom et une a 
péri d’une insuffisance cardiaque. Le traitement à 
conduit, chez les vaches du groupe B à des concentra-
tions sanguines de calcium significativement plus éle-
vées dans les premières 8 heures que chez celles du 
groupe A. D’autre part, l’administration, dans le groupe 
B, de phosphate de sodium a amené une élévation signi-
ficative et durable de la concentration de phosphate 
inorganique. Le pourcentage des animaux qui se sont 
levés dans les 8 heures et étaient guéris après un seul 
traitement était plus élevé dans le groupe B que dans le 
groupe A (P > 0.05). D’autres études, avec des nombres 
d’animaux plus importants, sont nécessaires pour 
conforter ces résultats.
Trattamento con calcio per via  
endovenosa e fosfato di sodio per  
via orale per le mucche affette da  
collasso puerperale
Si è esaminato se la somministrazione, nelle mucche 
affette da collassa puerperale, di 1000 ml di una solu-
zione al 40% di calcio borogluconato per via endove-
nosa e 500 g di fosfato di sodio per via orale, possa 
spesso mantenere una normocalcemia, una normofosfa-
temia e dare migliori risultati che la sola somministra-
zione di 500 ml di calcio borogluconato. Gli esami sono 
stati eseguiti su 40 mucche da latte affette da collasso 
puerperale. Tutte le mucche avevano inizialmente una 
ipocalcemia e una ipofosfatemia. Le mucche sono state 
alternativamente suddivise in due gruppi di trattamento 
A e B di ciascuno 20 mucche. Le mucche di entrambi i 
gruppi sono state trattate per via endovenosa con 500 ml 
di una soluzione al 40% di calcio borogluconato. Le 
mucche nel gruppo B hanno ricevuto inoltre 500 ml di 
calcio borogluconato via infusione endovenosa conti-
nua e 500 g di fosfato di sodio per sondino nasogastrico. 
Entro 8 ore, 32 mucche si erano alzate mentre 8 no. 
Delle 32 mucche alzate, 18 (90%) animali erano del 
gruppo B e 14 (70%) del gruppo A (p = 0.23). Purtrop-
po, 7 delle 32 mucche hanno subito una ricaduta. Delle 
7 mucche recidive e delle 8 che non si erano alzate entro 
le 8 ore, dopo una rinnovata infusione di calcio, 10 si 
sono levate. Cinque mucche hanno sviluppato la sin-
drome della “downer cow”, tra queste 3 erano guarite 
dopo una terapia intensiva. Il successo del trattamento 
globale non si differenziava tra i due gruppi in modo 
significativo. Nel gruppo A, 12 (60%) mucche e nel 
gruppo B, 14 (70%) erano guarite dopo un unico trat-
tamento. Delle restanti 14 mucche, 11 si sono alzate 
dopo due o più trattamenti. Due mucche hanno dovu-
to essere soppresse a causa della sindrome della “downer 
cow”, una invece è morta di insufficienza cardiaca. Il 
trattamento ha provocato nel gruppo B un aumento 
significativo della concentrazione di calcio nel sangue 
nelle prime 8 ore cosa non avvenuta nel gruppo A. In 
seguito, nel gruppo B si è rilevato mediante la sommi-
nistrazione di fosfato di sodio un aumento significativo 
e costante della concentrazione di fosfato inorganico 
nel sangue. La percentuale di mucche che si sono alzate 
entro 8 ore e guarite dopo un solo trattamento, era su-
periore nel gruppo B che nel gruppo A (P> 0.05). Per 
convalidare i risultati sono necessarie ulteriori analisi 
con un maggior numero di animali.
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